Gene Query: CYB5R1

Dataset Description Geneva Score
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 65.33
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 38.03
Tyrosine Kinase Inhibitor Cardiotoxicity 38.03
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 35.33
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 34.96
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 34.72
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 32.19
EP400 is required for Max and MCPyV mediated gene activation 31.24
Control of prostate tumour growth by the long non-coding RNA GHSROS 30.52
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 29.72
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 29.28
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 29.18
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 28.39
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 28.07
G-quadruplex structures mark human regulatory chromatin 26.59
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 24.66
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 24.66
RNA-seq differential expression studies: more sequence, or more replication? 23.99
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 23.98
Gene expression profiling of human and murine in vitro muscle differentiation 23.31
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 23.07
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 22.75
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 21.96
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 20.91
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 20.3
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 20.28
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 20.02
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 19.89
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 19.3
Gene expression profile of human placenta from T. Cruzi infected mothers 19.24
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 18.18
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 17.95
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 17.82
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 16.88
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 16.73
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 16.53
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 16.4
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 16.18
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 16.04
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 15.78
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 15.56
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 15.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 15.22
Effect of mitochondria deficiency on senescence-associated gene expression 14.88
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 14.61
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 14.61
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 14.53
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 14.35
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 14.32
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 14.21
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 14.21
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 14.19
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 14.16
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 13.91
NR2F2 study 13.91
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.77
CSL RNA-Seq on HKC and SCC cell lines 13.68
CSL 13.68
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.64
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.64
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 13.59
Transcriptome of human white and brown adipose tissue biopsies 13.56
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 13.55
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 13.55
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 13.23
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 13.0
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 13.0
Silencing p300 in MCF7 cells to study expression and alternative splicing 12.97
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 12.71
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 12.34
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 12.23
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 12.11
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 12.07
SUV420H2 knockdown in PANC-1 11.53
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 11.41
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 11.28
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 11.27
Generation of KRAS signatures using immortalized isogenic lung cells. 11.12
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.8
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 10.79
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.68
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 10.53
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 10.53
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.52
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.52
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.41
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.41
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.29
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.29
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 9.86
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 9.85
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 9.84
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 9.8
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 9.75
RNA-sequencing in immortalized human mammary epithelial cells 9.75
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 9.73
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 9.67
circRNA profile in hypopharyngeal cancer 9.56
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 9.47
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 9.47
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 9.43
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 9.34
Genome-wide functional assessment of enhancer activities in the human genome 9.32
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 9.3
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 9.3
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 9.28
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 9.28
RNA-Seq in PWS iPSC-derived neurons 9.07
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 9.05
LNCaP treated with iBET 9.03
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.03
Aneuploidy-induced cellular stresses limit autophagic degradation. 8.95
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 8.9
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 8.89
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 8.86
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.72
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.72
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 8.62
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 8.56
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 8.52
Genome wide expression change by RNF168 knocking down in NEC cells 8.31
The role of FAM46C in myeloma cells 8.31
The role of FAM46C in myeloma cells [sequencing] 8.31
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.28
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 8.23
Regulation of Lipids is Central to Replicative Senescence 8.23
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.22
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 7.96
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 7.94
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 7.92
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.92
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.92
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 7.87
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 7.87
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 7.85
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 7.82
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.82
RNA sequencing of mechanically strained NHEKs and control NHEKs 7.82
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 7.77
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 7.62
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 7.55
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.52
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.5
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 7.37
Generation and functional characterization of MDSC-like cells 7.36
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.28
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.28
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.26
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 7.17
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.16
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.15
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 7.15
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.14
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.14
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.09
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.09
Epigenome regulation during epidermal lineage commitment [RNA-seq] 7.07
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 7.02
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 7.0
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.89
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.84
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 6.78
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 6.76
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.66
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.65
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.63
Patient-derived luminal breast cancer xenografts with progestins 6.63
Expression profiling of MCF-7 cells with treatment of TCDD 6.61
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 6.61
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.58
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 6.57
Differential gene expression of human melanoma cells [RNA-seq] 6.54
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.54
Epigenome regulation during epidermal lineage commitment 6.54
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 6.54
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.53
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 6.44
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.43
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 6.37
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 6.36
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 6.34
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.31
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.31
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.3
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.3
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 6.29
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 6.28
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 6.28
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.25
A549 cells and MSR-A549 cells 6.25
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.25
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 6.25
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 6.23
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.23
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.23
SLIGRL-induced gene expression changes in NHEK cells 6.23
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.22
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.08
T47D RNA-seq and ChrRNA-seq data 6.08
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 6.05
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 6.05
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 6.03
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 6.03
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.98
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.86
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 5.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 5.8
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.79
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.79
The Human Testis Cell Atlas via Single-cell RNA-seq 5.79
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.79
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.78
GATA3-mediated chromatin reprogramming in breast cancer cells 5.78
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 5.76
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 5.75
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 5.75
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.74
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.71
Developmental stage specific chromosome architecture in human erythroid cells 5.71
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.69
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.67
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.67
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.66
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.64
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.64
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 5.64
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 5.6
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 5.6
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 5.6
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 5.59
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.58
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 5.58
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 5.57
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 5.54
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 5.47
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 5.47
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.45
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.45
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.42
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 5.38
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 5.38
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.35
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.35
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 5.32
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 5.3
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.3
The landscape of alternative splicing in aggressive prostate cancers 5.28
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.28
Biological effect of chronic mistranslation in mammalian cells 5.27
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 5.27
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.26
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.25
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.24
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 5.2
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 5.2
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.17
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.17
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 5.13
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.08
Tpl-2 and MEK small molecule inhibitors 5.08
Tpl-2 small molecule project 5.08
Mapping interactions for the TNIP2 hub protein 5.06
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.96
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.93
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.89
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.87
Analysis of transcriptional regulation by Myt1 and Myt1l 4.86
Hepatitis C virus functionally sequesters miR-122 4.81
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.81
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.78
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.75
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.69
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 4.65
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.65
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.65
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.62
CUREfast: Accelerating research with families 4.55
Conservative alteration of chromosomal expression pattern across human solid tumor types 4.55
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.47
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.46
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.45
Transcriptomic analysis of LSD1 4.43
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.43
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.43
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.4
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 4.4
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 4.39
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 4.39
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 4.38
Fbxo32 mediated gene expression program underlies EMT and metastasis 4.38
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.36
RNA-seq of shEZH2 cells 4.33
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.31
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.31
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.3
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.29
RNA-seq of IL-4 stimulated human keratinocytes 4.11
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.1
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.1
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 4.08
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.01
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.01
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 3.97
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 3.97
RNA editing in nascent RNA affects pre-mRNA splicing 3.92
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 3.81
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.8
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 3.79
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.79
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 3.78
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.73
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.73
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.69
Gene expression signatures of innate lymphoid cells from human blood 3.66
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.65
Induced DNA demethylation, genome instability and transcription 3.65
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.64
Global response to chemotherapy-induced apoptosis 3.63
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.61
Effect of ILF3 on translation during homeostasis and the antiviral response 3.56
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.56
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.54
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.53
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.53
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.5
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 3.49
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.48
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 3.39
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 3.39
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.39
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.38
Downregulation of LATS kinases alters p53 to promote cell migration 3.34
RNA Sequencing of Human iPS derived Cardiomyocytes 3.29
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 3.28
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 3.25
RNA-seq analysis upon ARID1B overexpression 3.2
Expression charcaterization of an internal protocol developed to differentiate RPE cells 3.19
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.16
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.16
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 3.14
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.14
RNAseq Study in CC-671 Treated Cal-51 Cells 3.09
EGR1-controlled transcriptome of T HESCs 3.03
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 3.01
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.01
Identification of the role of polydom in neurofibromas 2.99
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.99
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.98
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.98
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.97
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.97
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.97
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.97
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.92
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.9
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.89
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.88
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.88
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.84
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.82
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.82
Redifferentiation of expanded human islet β cells by inhibition of ARX 2.78
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 2.75
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 2.75
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.75
Epigenomic conservation of transposable element silencing 2.73
Epigenomic conservation of transposable element silencing [RNA-seq] 2.73
Measure transcript integrity using RNA-seq data 2.69
Discovering human diabetes-risk gene function with genetics and physiological assays 2.63
RNA sequencing of human mammary epithelial cells 2.63
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.6
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.58
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.53
Transcriptome sequencing of K-562 cells 2.51
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.46
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.46
2.45
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.42
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 2.39
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.38
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.32
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.26
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.26
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.26
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.25
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.25
Impact on erythroid progenitor type on erythroid differntiation 2.23
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.21
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.2
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.17
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 2.16
An acquired vulnerability of drug resistant melanoma with therapeutic potential 2.16
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.11
Identification of expressed and conserved human non-coding RNAs 2.04
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 2.01
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.0
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.0
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.99
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 1.99
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.98
Expression profiling of converted and control dermal BJ fibroblasts 1.98
Dilated cardiomyopathy vs Myocarditis 1.98
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.98
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.93
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.92
U2AF1 mutations alter splice site recognition in hematological malignancies 1.9
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.84
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.83
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.83
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.8
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.8
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 1.77
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 1.77
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.74
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.73
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.72
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.72
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.7
MRTF activates TEAD-YAP target gene expression 1.65
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.64
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.63
The DNA methylation landscape of human melanoma [RNA-Seq] 1.63
The DNA methylation landscape of human melanoma 1.63
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.62
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.62
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.58
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.57
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.43
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.43
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.42
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.42
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 1.4
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 1.4
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.39
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.38
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.37
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.33
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.33
BET bromodomain inhibition 1.3
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.3
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.28
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.27
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.19
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.19
RNAseq of cell lines with knocked in ESR1 mutations 1.16
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.14
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.14
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.13
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.1
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.09
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.07
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.07
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.05
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.01
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.99
Hepatic transcriptome of pediatric hepatoblastoma. 0.97
ML29755 RNA-seq data 0.97
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.96
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.92
Preclinical model of obesity and ER-positive breast cancer 0.86
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.84
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.83
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.78
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.78
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.67
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.67
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 0.67
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.64
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.6
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.58
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.57
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.56
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.56
Transcriptomic analysis of frontal fibrosing alopecia 0.51
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.49
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.49
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.49
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.49
Energy Metabolism during Anchorage-Independence 0.47
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.46
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.45
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.44
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.37
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.35
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.35
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.34
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.33
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.31
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.31
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.26
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.21
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.16
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.12
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.08
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.06
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.06
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.03
RNAseq of Breast cancer PDX samples 0.02
Gene expression changes due to PARP knockdown in human cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation